From Washington State activist John Novak January 9, 2015:
This article includes a large number of links to public records, news articles and other information. If this email does not contain all the hyperlinks, please go to the following links..Please be patient as the site is experiencing heavy volume of visitors and is being adjusted accordingly.
Online at: http://420leaks.com/?p=689
On Facebook at:
(We will follow up this email soon with our proposed solutions.)
Subject: I-502: OPMA, MMJ, Public Records and the “Partnership”
By John Worthington (background research also by Arthur West, John Novak)
(All exhibit links to box.com are from public record files in PDF format)
One of the main goals of Initiative I-502, as originally written and passed, was allegedly to create a policy change from enforcing marijuana crimes, to properly enforcing property crimes by ‘legalizing” marijuana for persons over 21.
Once the “legalization” initiative passed, the marijuana prohibition stakeholders, AKA the “partnership” went to work to reverse the policy goals outlined in I-502. (Exhibit 1 https://app.box.com/s/rmgcsqu9eknlx5zbp7o9
Despite the best efforts to hide these meetings
, enough information began to leak out to the marijuana activists, that they were able piece together how the “partnership,” influenced the WSLCB. The documents they obtained show how the “partnership” set out to increase local law enforcement funding and de-incentivize medical marijuana.
The messages and goals for this new Meta organization was clear, get rid of medical marijuana, and divert I-502 revenue to the cities and counties.
According to the notes from these secret Liquor Control Board meetings with local, state and federal agencies set up by the AWC, medical marijuana was no longer needed because the State now had a “legal” marijuana system.
The WSLCB arranged to have the legislature “give them cover”, by creating legislation that would allow them a “place at the table,” for medical marijuana discussions. This strategy is outlined in an email from WSLCB board member Chris Marr to the agency director, Rick Garza. (Exhibit 3 https://app.box.com/s/di9dkswq8v250c5ihs8u
Eickmeyer, through Senator Rivers, proceeded to draft SB 5887
, which proposed to create a medical marijuana work group, however, the bill did not pass.
Senator Rivers and Eickmeyer then acted to get a medical marijuana work group passed “Amendment #224” in the state’s budget bill, SB 5034, to which Senator Jeanne Kohl-Welles objected to because “too many conclusions would be drawn behind closed doors. Senator Kohl-Welles put out an email on June 2, 2014 addressing concerns about the process.
“It has also has resulted in a high level of concern on the part of many patient and other advocacy groups — including even outright opposition being expressed in rallies and demonstrations. I am concerned that we would be handing over too much of our responsibility to a regulatory agency. I also worry that too many conclusions would be drawn behind closed doors, and that the process for creating these rules would circumvent public input.
In many ways, the LCB has a vested interest in diverting business from the medical collectives now operating and into the retail stores when they open early next year. It is easy to argue the LCB also has a vested interest in wanting to add to its regulatory scope, and bring the medical cannabis industry into its system. This may turn out to be the end result down the road, or it may be determined that another state agency should have that responsibility.
For these and other reasons, I think it best to have the LCB focus on its task at hand, that given to them by the voters in approving I-502 — an initiative that specifically mentions it will have no effect on medical cannabis laws.”
Essentially, the federal government also had a hand in I-502 secret rulemaking process through the cross designated members of the WSP
and in direct meetings with the DEA and U.S. Attorney’s office.
Soon after the passage of initiative I-502, the broad and powerful “partnership” had managed to convert the policy goals of redirecting law enforcement funding to property crimes to adding local law enforcement funding and getting rid of medical marijuana.
The Washington State Liquor Control Board had arranged its “place at the table”, and the “partnership”, managed to set forth a mechanism to glean law enforcement funding increases and interfere with medical marijuana laws when I-502 appeared to advertise just the opposite. (Exhibit 7 https://app.box.com/s/uhke9k9wda5tdjsx93cs
For its part the work group, began its job of eliminating or de-incentivizing medical marijuana under the guise of merging it with recreational marijuana. (Exhibit 8 https://app.box.com/s/rdkfowosyuwyzodgyzs4
The Governor’s office, with help from the local U.S. Attorney Jenny Durkan did their part by making sure the public knew that the medical marijuana situation was “untenable”. (Exhibit 9 https://app.box.com/s/c5m8ogtl8hod59lmewbr )
The urgency for a “robust” regulatory system for marijuana was further ratcheted up with the use of a document referred to as the “Cole Memorandum”, which was actually requested by the LCB, and not a mandate generated by the U.S. Attorney’s office at the request of the Governor’s office. (Exhibit 10 https://app.box.com/s/o4cips7jho2mejgho5cs
The following legislative session in 2014, SB 5887 and a new bill from Senator Jeanne Kohl Welles SB 6178, offered two approaches on how to integrate and de-incentivize medical marijuana. Representative Eileen Cody also proposed HB 2149 that same legislative session.
The legislators had several major hurdles to clear in order to kill medical marijuana. The most formidable of which was the fiscal impacts of the “robust” regulatory system which now included more law enforcement funding not included in the I-502 earmarks.
The fiscal notes to the Ways and Means and House Finance committees, which were put forth at the last second, did not include the actual cost of implementing the ratcheted up “robust” marijuana regulatory scheme.
Furthermore, the small business impact studies were incomplete further misleading the actual financial impact of the medical marijuana killing legislation.
“The argument for the initiative was that it’s going to lower public safety costs, and now they’re saying it’s going to increase public safety costs with absolutely no data. (It’s) troubling,” said House Finance Committee Chairman Reuven Carlyle
(D-Seattle) in an interview
Many marijuana activists claimed victory when all the medical marijuana bills failed to pass out of the 2014 legislative session.
The 2015 legislative session is underway and the legislature should be informed of what the I-502 rule making process has become so they can properly achieve policy goals set forth by the public.
GeoNovus Minerals Corp.
GeoNovus Launches Innovative Cannabinoid Initiative in Uruguay – See more at:
VANCOUVER, British Columbia, Sept. 18, 2014 (GLOBE NEWSWIRE) — There are 5,000 pending patents on different cannabinoid compounds at the U.S. Patent Office – most of them registered by Pharmaceutical companies who are intending to commercialise the naturally occurring compound found in the Cannabis Sativa.
GeoNovus (CSE:GNM) (GMINF-USA) is a Canadian company positioning itself to benefit from a research explosion that is expected to drive the legal marijuana market from $1.53-billion in 2013 to $2.57-billion by the end of 2014.
On June 26, 2014 GeoNovus announced that it has signed a letter of agreement with a Uruguay company actively working in multiple areas of the medical marijuana, industrial hemp and cannabinoid science industries to develop products for consumer use.
The initiation of the agreement within Uruguay gives GeoNovus pioneering and exclusive rights to acquire and participate in multiple business ventures in Uruguay including: growing facilities, cannabinoid product development, medicinal trials and industrial hemp product development.
Uruguay recently became the first country in the world to legalize the sale cultivation and distribution and consumption of cannabinoids in December of 2013.
“I got involved with medical marijuana in 2001, when my mother was diagnosed with ovarian cancer,” stated Julian Strauss, GeoNovus Uruguayan Operations Manager in an exclusive interview with Financial Press, “we discovered it had medicinal properties not available from conventional drugs.”
In Vancouver, BC Strauss collaborated with researchers from the University of British Columbia and formed a compassion club, developed “partial decarboxylation delivery systems” for patients dealing with painful side-effects of therapeutic treatments for multiple sclerosis and cancer. The club organised informal trials, and the results went off the charts.
“At that point I started reaching out to doctors,” stated Strauss, “We collected patients, grew medical marijuana, created oil extracts and collaborated with health authorities and doctors. It was impossible grow enough marijuana to satiate the demand for medicinal oils.”
The team created proprietary collection systems to produce oils on an industrial level, anticipating that Canada would deregulate, and they could begin human trials with the developed intellectual property or “IP”.
“The de-regulation did not come in a way that was helpful to us,” stated Strauss, “The narrative in Canada changed to guys in dread-locks promising to save the world. So I got on a plane to Uruguay and began discussions with the Latin American scientific community, and also with regulators and legislators. We are now building a legal and logistical framework for the development and commercialisation of cannabinoids in partnership with Uruguayan government bodies, universities, and growers clubs.”
Strauss believes the quickest route to cash flow in the marijuana industry is by creating infrastructure for clinical hemp and marijuana trials, and then creating protocols for lab studies, full-spectrum therapies, chemical and mechanical fiber analysis.
“The 5,000 pending patents tell the story,” stated Strauss, “Research into the uses of cannabinoids is about to explode. We can offer entrepreneurial companies an environment to collect data, run trials and ultimately register intellectual property. For providing this service in Uruguay, our company will maintain a royalty percentage. We believe there is a great financial opportunity in helping to legitimize cannabis technology companies.”
“Dry cannabis is a smokescreen thrown up to regulate the medicinal value of cannabis,” explains GeoNovus President Michael England, “This is not where we see the big business opportunity. There is a $200 billion dollar industry waiting in the wings for deregulation. We intend to create manufacturing protocols for specific pathologies. By establishing operations in Uruguay, we can get in on the ground floor.”
Cannabinoids are one of the only compounds in nature that naturally break down the blood barrier in the spine and brain. MRIs and CAT scans of the body’s reaction to therapeutic treatment confirm the endless potential for hemp-based homeopathic remedies.
“Every pharmaceutical company in the world is creating allopathic carbon-based lab derivatives of cannabinoids to try and mimic the natural function found within the plant’s genome,” stated England, “But natural cannabinoids are the answer, and for that they will need a scientific and regulatory environment that promotes experimentation and clinical trial. Uruguay provides us with all of these factors as well as access to a significant pool of professional expertise – Big Pharma will be taking notice.”
Therapeutic cannabinoid treatments for all types of ailments from multiple sclerosis and cancer to headaches and seizures are quickly becoming a popular alternative to traditional chemo and medicines. Ground-breaking cannabinoid research being conducted by companies like GeoNovus in “Cannabis friendly” countries like Uruguay will pave the way for the future of these emerging alternative therapies.
GeoNovus is currently trading at $0.04 with a market cap of only $2 million under the symbol GNM on the Canadian Securities Exchange (CSE) and GMINF in the USA.
Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.
Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.
GeoNovus Minerals Corp
1220 789 West Pender Street
Vancouver, BC, Canada
Toll Free: 1-888-945-4770
– See more at: http://globenewswire.com/news-release/2014/09/18/666960/10099121/en/Cannabinoids-Create-Log-Jam-at-U-S-Patent-Office.html#sthash.v2NSqKOD.dpuf
Date: October 20, 2014
Source: European College of Neuropsychopharmacology (ECNP)
Summary: A large UK study has found that occasional adolescent cannabis use does not lead to poorer educational and intellectual performance, but that heavy cannabis use is associated with slightly poorer exam results at age 16.
A large UK study has found that occasional adolescent cannabis use does not lead to poorer educational and intellectual performance, but that heavy cannabis use is associated with slightly poorer exam results at age 16. The results come from the Avon Longitudinal Study of Parents and Children (ALSPAC, also known as “Children of the 90’s”) a long-term study that follows the health of children born in the Bristol area (UK) in 1991 and 1992. The work is being presented at the annual congress of the European College of Neuropsychopharmacology (ECNP) in Berlin.
The researchers analysed data from 2,612 children who had their IQ tested at the age of 8, and again at the age of 15. These children’s examination results were then factored in via the National Pupil Database. At the age of 15, each person in the study completed a survey on cannabis use. The researchers then used regression analysis to look at how cannabis use affected both intellectual and educational performance. A number of children could not be included in the final analyses (for example because they had experienced a head injury), leaving a total sample size of 2,235.
The researchers found two main points
- Cannabis use appeared to be associated with decreased intellectual performance. Cannabis use was, however, highly correlated with other risky behaviours such as alcohol, cigarette and other drug use. When the researchers took these other behaviours into account, they found there was no relationship between cannabis use and lower IQ at age 15.
- Heavier cannabis users (at least 50 times by age 15) however, did show marginally impaired educational abilities. These children tended to have poorer exam results (3% lower) on compulsory school exams taken at age 16, even after adjusting for childhood educational performance, as well as alcohol, cigarette and other drug use.
According to lead researcher, Claire Mokrysz (University College London):
“Our findings suggest cannabis may not have a detrimental effect on cognition, once we account for other related factors- particularly cigarette and alcohol use. This may suggest that previous research findings showing poorer cognitive performance in cannabis users may have resulted from the lifestyle, behaviour and personal history typically associated with cannabis use, rather than cannabis use itself.
People often believe that using cannabis can be very damaging to intellectual ability in the long-term, but it is extremely difficult to separate the direct effects of cannabis from other potential explanations. Adolescent cannabis use often goes hand in hand with other drug use, such as alcohol and cigarette smoking, as well as other risky lifestyle choices.
It’s hard to know what causes what- do kids do badly at school because they are smoking weed, or do they smoke weed because they’re doing badly? This study suggests it is not as simple as saying cannabis is the problem.
This is a potentially important public health message- the belief that cannabis is particularly harmful may detract focus from and awareness of other potentially harmful behaviours. However the finding that heavier cannabis use is linked to marginally worse educational performance is important to note, warranting further investigation.”
Commenting ECNP Chair, Professor Guy Goodwin (Oxford) said “This is a potentially important study because it suggests that the current focus on the alleged harms of cannabis may be obscuring the fact that its use is often correlated with that of other even more freely available drugs and possibly lifestyle factors. These may be as or more important than cannabis itself.”
The researchers noted that the study has some limitations. For example, cannabis use was self-reported, and the measure of IQ taken at age 15 was an abbreviated version of the standard Wechsler IQ test.
Full details can be found in the abstract (however please note that the abstract shows a preliminary analysis; this may differ from the version which is currently being prepared for publication and which is described above).
The above story is based on materials provided by European College of Neuropsychopharmacology (ECNP). Note: Materials may be edited for content and length.
Cite This Page:
European College of Neuropsychopharmacology (ECNP). “No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows.” ScienceDaily. ScienceDaily, 20 October 2014. .
Science Daily October 7, 2014
In the past 20 years recreational cannabis use has grown tremendously, becoming almost as common as tobacco use among adolescents and young adults, and so has the research evidence. A major new review in the scientific journal Addiction sets out the latest information on the effects of cannabis use on mental and physical health.
The key conclusions are:
Adverse Effects of Acute Cannabis Use
- Cannabis does not produce fatal overdoses.
- Driving while cannabis-intoxicated doubles the risk of a car crash; this risk increases substantially if users are also alcohol-intoxicated.
- Cannabis use during pregnancy slightly reduces birth weight of the baby.
Adverse Effects of Chronic Cannabis Use
- Regular cannabis users can develop a dependence syndrome, the risks of which are around 1 in 10 of all cannabis users and 1 in 6 among those who start in adolescence.
- Regular cannabis users double their risks of experiencing psychotic symptoms and disorders, especially if they have a personal or family history of psychotic disorders, and if they start using cannabis in their mid-teens.
- Regular adolescent cannabis users have lower educational attainment than non-using peers but we don’t know whether the link is causal.
- Regular adolescent cannabis users are more likely to use other illicit drugs, but we don’t know whether the link is causal.
- Regular cannabis use that begins in adolescence and continues throughout young adulthood appears to produce intellectual impairment, but the mechanism and reversibility of the impairment is unclear.
- Regular cannabis use in adolescence approximately doubles the risk of being diagnosed with schizophrenia or reporting psychotic symptoms in adulthood.
- Regular cannabis smokers have a higher risk of developing chronic bronchitis.
- Cannabis smoking by middle aged adults probably increases the risk of myocardial infarction.
The above story is based on materials provided by Wiley. Note: Materials may be edited for content and length.
Cite This Page:
Wiley. “What 20 years of research on cannabis use has taught us.” ScienceDaily. ScienceDaily, 7 October 2014. .
****Note from Anna: Clearly the research is negatively biased but it is always good to understand how MMJ patients can be manipulated into using harmful chemical drugs by doctors.
Research here: Granny Storm Crow’s 2014 Cannabis research link list:
Calgary Medicinal Marijuana Center
U.S. medical marijuana patent 6113940 information:http://www.freepatentsonline.com/6113940.pdf
PATENTS RELATED TO CANNABIS
2000 – US Patent 6132762 ~ Transcutaneous application of marijuana
2000 – US Patent 6113940 ~ Drug delivery with transdermal patch layer which carries the cannabis chemical(s). the chemicals are contained in a film on the
2001 – US Patent 6328992 ~ Cannabinoid patch and method for cannabis transdermal delivery
2002 – US Patent 6383513 ~ Compositions comprising cannabinoids (nasal spray)
2002 – US Patent 6410588 ~ Use of cannabinoids as anti-inflammatory agents
2003 – US Patent 6630507 ~ Cannabinoids as antioxidants and neuroprotectants
2003 – US Patent 6503492 ~ An antiperspirant or deodorant active agent comprising an aluminium and/or zicronium salt or complex, a carrier for active agent and a cannabanoid receptor (CBR) activating agent
2004 – US Patent 20070151149 ~ Methods for altering the level of phytochemicals in plant cells by applying wave lengths of light from 400 nm to 700 nm and apparatus therefore
2003 – US Patent Application 2004004905 ~ Method for producing an extract from cannabis
plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
2004 – US Patent 6713048 ~ Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers
and methods of use
2005 – US Patent 6974568 ~ Treatment for cough
2005 – US Patent Application 20050266108 ~ Methods of purifying cannabinoids from plant
2005 – US Patent Application 20050079136 ~ Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery
2005 – US Patent 6949582 ~ Method of relieving analgesia and reducing inflamation using a
cannabinoid delivery topical liniment
2005 – US Patent 20050070596 ~ Methods for treatment of inflammatory diseases using CT-3 or analogs thereof
2006 – US Patent Application 20060160888 ~ Room-temperature stable dronabinol formulations
2006 – US Patent 7088914 ~ Device, method and resistive element for vaporizing a medicament
2006 – US Patent Application 20060167084 ~ Delta-9-THC compositions and methods for
treating symptoms associated with multiple sclerosis
2006 – US Patent 7025992 ~ Administering lipophilic drug through mucous membranes
2006 – US Patent Application 20060039959 ~ Film-Shaped Mucoadhesive Administration Forms
For Administering Cannabis Agents
2006 – US Patent 7109245 ~ Vasoconstrictor cannabinoid analogs
2007 – US Patent Application 20070020193 ~ Dronabinol compositions and methods for using
2007 – US Patent 20080057117 ~ Pharmaceutical Composition Made Up Of Cannabis Extracts
2007 – US Patent Application 20070041994 ~ Aqueous extract of finely chopped dried selenium- and zinc-enhanced cannabis (Cannabis indicaxCannabis ruderalis), chopped shiitake mushrooms (Lentinula edodes), and chopped maitake mushrooms (Grifola frondosa) packaged in a cellulose capsule for oral adminstration to treat prostatitis, prostate cancer
2007 – US Patent Application 20070049645 ~ Anti-nausea and anti-vomiting activity of
2007 – US Patent Application 20070099987 ~ Treating or preventing diabetes with cannabidiol
2008 – US Patent 7344736 ~ Extraction of pharmaceutically active components from plant materials
2008 – US Patent 20080275237 ~ Method for Obtaining Pure Tetrahydrocannabinol
2008 – US Patent 7402686 ~ Cannabinoid crystalline derivatives and process of cannabinoid
2008 – US Patent 7399872 ~ Conversion of CBD to Δ-THC Delta 8 and Δ-THC Delta 9
2008 – US Patent Application 20080112895 ~ Aqueous dronabinol formulations (Cannabinoids in buffer/cosolvent such as ethanol, propylene glycol and/or polyethylene glycol; ophthalmology)
2008 – US Patent Application 20080181942 ~ Delta-9-THC compositions and methods for
treating symptoms associated with multiple sclerosis
2008 – US Patent Application 20080262099 ~ Inhibition of Tumour Cell Migration
2008 – News ~ US Government Holds Patent For Medical Marijuana, Shows Hypocrisy
2009 – US Patent Application 20090324797 ~ Modulating Plant Oil Levels
2009 – US Patent 7622140 ~ Processes and apparatus for extraction of active substances and
enriched extracts from natural products
2009 – US Patent Application 20090197941 ~ Pharmaceutical Compositons for the Treatment of
Chronic Obstructive Pulmonary Disease
2010 – US Patent Application 20090005461 – Use of Cannabidiol in the Treatment of Hepatitis
2010 – US Patent 2623723 ~ Process for production of delta-9-tetrahydrocannabinol
2010 – US Patent Application 20100249223 ~ New use for cannabinoid-containing plant extracts
2010 – US Patent Application 20100239693 ~ Cannabinoid-containing plant extracts as neuroprotective agents
2010 – US Patent Application 2004014385 ~ Pharmacological treatment of psoriasis
2010 – US Patent Application 20100012118 ~ Medicament dosage for inhaler
2010 – US Patent 7741365 ~ Peripheral cannabinoid receptor (CB2) selective ligands
2010 – US Patent Application 20100204312 ~ Methods and compositions for treating cancer
2010 – US Patent Application 20100158973 ~ Therapeutic uses of cannabidiol compounds
2010 – US Patent Application ~ Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
2011 – US Patent Application 20110097283 ~ Chewing gum compositions comprising cannabinoids
2011 – US Patent 2005023741 ~ Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
2011 – US Patent Application 20110052694 ~ Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
2011 – US Patent Application 20110073120 ~ Smoke and Odor Elimination Filters, Devices and
2011 – US Patent Application 20110020945 ~ Oral detection test for cannabinoid use
2011 – US Patent Application 20110082195 ~ New use for cannabinoids
2011 – Patent GB2478595 ~ Phytocannabinoids for use in the treatment of cancer
2012 – US Patent 20120052119 ~ Nanoencapsulated delta-9-tetrahydrocannabinol
2012 – US Patent US2012046352 ~ Controlled cannabis decarboxylation
2012 – US Patent US2012034293 ~ Transdermal delivery of cannabinoids
2012 – US Patent Application 20120004251 ~ Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy
2012 – US Patent 7674922 ~ Process for production of delta-9-tetrahydrocannabinol
2012 – US Patent Application 20120264818 ~ Topical Compositions with Cannabis Extracts
2013 – US Patent Application 20130245110 ~ The use of CBD alone or in combination with another cannabinoid (also THCV alone)
2013 – US Patent 8435556 ~ Transdermal delivery of cannabidiol
2013 – US Patent Application 20130280343 ~ Food Products Derived From Cannabinoid-Administered Livestock
2013 – US Patent Application 20130171145 ~ Methods of treating liver disease
2013 – US Patent Application on 20130251824 ~ Recycling cannabinoid extractor
2013 – US Patent Application 20130059018 ~ Phytocannabinoids in the treatment of cancer
2013 – US Patent NEWS ~ GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabinoids in Treating Glioma
- High levels of radiation found at Fukushima, 460,000 Bq/L; Removing fuel in unit 1 storage pool to start 2017 — NHK World
***Note from Anna: Sometimes I rant, hence the origin of my blog name. So this is for all of the scientists, farmers, educators, politicians, parents, doctors, and advocate in the United States:
1. YOU CAN’T GROW ANYTHING WITH SEVERELY RADIOACTIVE WATER. 2017 is TOO LATE FOR A CLEANUP.
2. THERE ARE FIFTY-FIVE NUCLEAR REACTORS ON A SET OF ISLANDS THAT CAN FIT ENTIRELY WITHIN THE STATE OF CALIFORNIA. AN EARTHQUAKE SWARM WILL PUT JAPAN COMPLETELY UNDER WATER AND FILL THE WORLD WITH RADIOACTIVE CLOUDS.
3. THE MOX FUEL BEING RELEASE ***CANNOT*** BE CLEANED WITH CURRENT TECHNOLOGY. YOUR KIDS ARE GOING TO BE STERILE, YOUR CROPS ARE GOING TO DIE, AND THERE WILL NEVER BE ENOUGH DOCTORS WORLDWIDE TO TREAT ALL THE CANCER PATIENTS BECAUSE THE DOCTORS WILL HAVE CANCER TOO!!!
4. THE POLITICIANS IN BOTH COUNTRIES HAVE *DELIBERATELY* FAILED US. THEIR ACTIONS ARE ACTS OF MASS MURDER AND TREASON.
5. GENERAL ELECTRIC AND TEPCO ARE 100% CULPABLE AND NEED TO IMMEDIATE PAY FOR THE EVACUATION AND RELOCATION OF ALL JAPANESE CITIZENS TO SAFE HAVENS.
By 2015 you realize what everyone has been saying when the following things start to occur:
Widespread immune, neurological, and muscular disorders.
Soldiers from Japan being deactivated from service due to Hodgkin’s Lymphoma cancers.
Mass heart attacks.
Mass outbreaks of cancer similar to what is currently happening in Malibu, California.
Widespread crops death including vegetables, fruits, wheat, hemp, and marijuana. You can’t grow organic medications if your crops are contaminated.
Inability to create medicine to handle the creation of new medicines because the researchers and scientists will also be getting sick and dying.
Outbreaks in crimes and cultural misunderstandings as sick people from Japan come seeking safe haven, which they should ABSOLUTELY get because AMERICA was complicit in poisoning them. if the situation was reversed American citizens would want, and demand, the same kind of help.
Budgetary crashes resulting in lack of FEMA or police resources.
You’ve been warned. DO SOMETHING!
Prescription drug abuse is an epidemic in Washington state. There are more deaths annually from prescription drug abuse than from meth, cocaine, and heroin combined.
What’s causing this epidemic? Drugs like OxyContin, Vicodin, and Methadone are now commonly prescribed for pain. Painkillers offer relief to millions of Americans but present a hidden danger.
These kinds of prescription drugs are called “opiates.” The American Heritage Dictionary defines “opiate” as a sedative narcotic, “[C]ontaining opium or one or more of its natural or synthetic derivatives.” In a way, these drugs are the cousins of a better known—and more feared— drug: heroin. But unlike heroin, most people don’t know how potentially addicting and dangerous prescription opiates can be.
Some recreational users crush prescription painkillers and then ingest them in order to bypass the time-release function of the medications. This provides a somewhat immediate, and sometimes deadly, high.
When overdosed, prescription painkillers can cause a significant decrease in lung function and death. They can also be lethal when they’re combined with other prescribed or over-the-counter drugs. High-profile deaths include actor Heath Ledger, who died from a lethal combination of oxycodone, hydrocodone, diazepam, temazepam, alprazolam and doxylamine.
Teenagers are increasingly experimenting with drugs commonly found in their parents’ medicine cabinets. According to the Healthy Youth Survey, 12 percent of 12th graders used prescription pain medications to get high in the past 30 days. The same survey also shows that an alarming number of younger kids experiment with these drugs. That’s why it’s critical to learn how to properly safeguard and dispose of your medications.
The Office of National Drug Control Policy reports that more than 47 percent of teens get prescription drugs from their friends for free. About 10 percent buy them from their friends, and another 10 percent take them from friends without asking.
The Attorney General’s Office uses funds from consumer protection settlements with drug manufacturers—including the makers of OxyContin— to provide grants to promote drug abuse prevention and prescription drug safety. To date those grants have totaled more than $2.7 million and include:
- $1,000,000 dollars to fund the Washington Prevention Summits and Spring Youth Forums, where kids learn to use the latest technology to create prevention programs in their schools.
- $683,000 to the State Department of Health to create a prescription drug monitoring program to prevent the “doctor shopping” that allows addicts to get access to dangerous drugs.
- $400,000 for the University of Washington to educate doctors on drug marketing. The funding is a portion of the $9 million awarded in grants nationwide from a settlement with Neurontin.
- $30,000 to The Pacific Northwest Pollution Prevention Resource Network to develop the Unwanted Medicine Return Program. This program promotes drug safety and a cleaner enviornment by promoting the safe disposal of unwanted medications.
- $15,000 for Prescriptions for Life, a local nonprofit organization working to eliminate prescription drug abuse. The money will help pay for a new educational video that will be shown to students, teachers, school counselors, law enforcement, medical professionals and civic and business leaders.
- $400,000 for the Washington Health Foundation launch a program to reduce prescription and over-the-counter drug abuse among college students, creating one of the first programs in the nation to target young adults between the ages of 18 to 24 (more below).
According to DOH, American Indians and Alaska Natives are hardest-hit by prescription drug abuse.
The AGO has addressed this issue by targeting a series of grants for programs that address substance abuse prevention programs in tribal communities:
- $101,700 for the Boys & Girls Club of America to establish two new clubhouses on Native American lands by 2011, targeting ages 7-18. The two anticipated newly established clubs on reservation lands should see an enrollment per club in excess of 700 youth. Boys & Girls Club substance abuse programs include SMART (Skills, Mastery And Resistance Training) Moves.
- $198,550 to the Northwest Portland Area Indian Health Board to provide four “mini-grants” of $30,000 each to tribal partners for community based projects to fight prescription drug abuse, and to fund a one-day regional training conference on prescription abuse among tribal members.
- $25,250 to Evergreen Council on Problem Gambling to help pay for a 6-day youth camp called New Directions: Tribal Youth Music Academy for Addiction Awareness & Prevention.
The Attorney General’s Office has partnered with the Washington Health Foundation, the Pharmaceutical Research Manufacturers of America (PhRMA) and other national organizations to provide an online health community and a set of resources to help college kids confront the prescription drug epidemic.
The Washington Health Foundation asks college students to be part a part of the solution – to help address prescription and over-the-counter drug misuse and abuse. Learn more on The Washington Health Foundation’s Web site. There, you can tell your story, share your ideas, explore innovative resources, and participate in social media discussions.
Uploaded on Aug 21, 2011
This is by far the best collection of educational material I have ever seen and I Highly recommend everyone here to really take/give your time and Look at it and bring all your Family / Classmates / Colleagues and friends together and educate your selves about the Most important thing on Earth
The importance of having those conversations about cannabis
Originally posted on Cannabis Patients Alliance:
2011 was a life-changing year for my husband and me. After he got laid off from his job, we decided to put most of our worldly belongings into storage and take off with our 4 dogs in our 22-foot motorhome. Aside from camping and hiking, we spent most of 8 months traveling around Colorado talking to people about marijuana. We talked to patients, dispensary workers, growers, and just average citizens. We wanted to get a feel for what the state, outside of Denver, thought about medical marijuana in Colorado.
I have a lot of conversations with a lot of people, usually about marijuana. People are so curious. I never really know what impact these conversations have. I just try to open people’s minds to new possibilities.
The other day I got a surprising message from someone I met back in 2011 but haven’t talked with since. She reminded me of our…
View original 395 more words
1) Each member of the governing body who attends a meeting of such governing body where action is taken in violation of any provision of this chapter applicable to him or her, with knowledge of the fact that the meeting is in violation thereof, shall be subject to personal liability in the form of a civil penalty in the amount of one hundred dollars. The civil penalty shall be assessed by a judge of the superior court and an action to enforce this penalty may be brought by any person. A violation of this chapter does not constitute a crime and assessment of the civil penalty by a judge shall not give rise to any disability or legal disadvantage based on conviction of a criminal offense.
(2) Any person who prevails against a public agency in any action in the courts for a violation of this chapter shall be awarded all costs, including reasonable attorneys’ fees, incurred in connection with such legal action.
Pursuant to RCW 4.84.185, any public agency who prevails in any action in the courts for a violation of this chapter may be awarded reasonable expenses and attorney fees upon final judgment and written findings by the trial judge that the action was frivolous and advanced without reasonable cause.
2012 c 117 § 126; 1985 c 69 § 1; 1973 c 66 § 3; 1971 ex.s. c 250 § 12.]
From the Washington Cannabis Institute ANovember 18, 2013:
The rules governing the implementation of I-502 limit pesticides that may be used to produce recreational marijuana. The Washington State Liquor Control Board (WSLCB) and the Washington State Department of Agriculture (WSDA) recently produced the list of acceptable pesticide products.
Only authorized pesticide products may be used. Using an unauthorized pesticide is a public safety license violation and can result in the cancellation of a producer’s license (see WAC 314-55-520).
WAC 314-55-010(13) defines a pesticide as meaning, but is not limited to: (a) Any substance or mixture of substances intended to prevent, destroy, control, repel, or mitigate any insect, rodent, snail, slug, fungus, weed, and any other form of plant or animal life or virus, except virus on or in a living person or other animal which is normally considered to be a pest; (b) any substance or mixture of substances intended to be used as a plant regulator, defoliant, or desiccant; and (c) any spray adjuvant. Pesticides include substances commonly referred to as herbicides, fungicides, and insecticides.
Licensed producers can use pesticides registered by WSDA under chapter 15.58 RCW that are allowed for use in the production, processing, and handling of marijuana.
If a particular pesticide is not consistent with the allowable pesticide criteria WSDA uses for marijuana production, the applicator could unknowingly be in violation of Washington pesticide laws (RCW 15.58.150(2)(c) and WAC 16-228-1500(1)(b)).
We recommend that pesticides from the OMRI list be cross-checked with the list of over 200 pesticides registered by WSDA that are allowable for use in marijuana production in PICOL.
A preliminary list of over 200 pesticides registered by WSDA under chapter 15.58 RCW that are allowed for use in the production, processing, and handling of marijuana can be found at Washington State University’s (WSU) PICOL (Pesticide Information Center Online) database at:
Under the “crop” drop-down menu choose: “I-502/I-692 (WA Only).”
PICOL lists the regulatory status of pesticides, as determined by WSDA. Updates can be made on a daily basis as pesticides are registered (and cancelled) by WSDA.
Using the PICOL Database
WSU has prepared tutorials as a starting point for prospective marijuana producer applicants in using the PICOL database.
If you have any questions, please contact the WSLCB Marijuana Licensing Unit at firstname.lastname@example.org.
(1) The director may deny, suspend, or revoke any provision of a license, registration, permit or certification issued under chapters 17.21 and 15.58 RCW if it is found that the applicant or the holder of the license, permit, or certification has committed any of the following acts each of which is declared to be a violation
Guidance–BSA Expectations Regarding Marijuana-Related Businesses
Posted in General
One of the things that has always fascinated us since we started our cannabis business law practice back in 2010, is how incredibly few lawyers have ever voiced any opposition — virtually zero. Lawyers are lawyers and that means we are legalistic and logical and lawyers usually give us the following four, eminently practical, logical and legalistic reasons for believing in legalization:
- There’s no reason to treat alcohol and pot differently under the law.
- Our pot laws are not fairly applied and they never will be. Wealthy White kids get off easy, poor African-American kids don’t. This sort of inequality of enforcement and punishment weakens our laws and weakens our legal system, and that is not a good thing. Without support by the people and legitimacy, law means little.
- We spend money on pot prohibition that would be better spent elsewhere.
- Much illegal pot money goes to funding gangs. We need to cut that off.
Uber-scientist Albert Einstein apparently thinks like a lawyer in that during prohibition he talked about how the flouting of some laws leading to the flouting of others:
The prestige of government has undoubtedly been lowered considerably by the prohibition law. For nothing is more destructive of respect for the government and the law of the land than passing laws which cannot be enforced. It is an open secret that the dangerous increase of crime in this country is closely connected with this.”
The same is true of pot.
As lawyers wanting rule by law, we support legalization.
The state of Washington is one of only nine states that does not levy a personal income tax nor a corporate income tax.
There is no inheritance tax, but the state imposes an estate tax on estates in excess of $2 million at rates ranging from 10% to 19%.
Washington State Tax Questions & Answers – Business, audits, e-filing, general questions.
Where to mail FEDERAL IRS tax forms within Washington State:
|If you ARE NOT enclosing a payment, use this address:
||If you ARE enclosing payment, use this address:
|Department of the Treasury
Internal Revenue Service
Fresno, CA 93888-0002
|Internal Revenue Service
P.O. Box 7704
San Francisco, CA 94120-7704
|Department of the Treasury
Internal Revenue Service
Fresno, CA 93888-0015
|Internal Revenue Service
P.O. Box 7704
San Francisco, CA 94120-7704
||Department of the Treasury
Internal Revenue Service
Fresno, CA 93888-0014
|Internal Revenue Service
P.O. Box 7704
San Francisco, CA 94120-7704
Other useful Web links to WA taxpayers associations, CPA groups,
business organizations or general U.S. state tax facts & information :
Moving to Washington State – Cost of Living, Taxes, Jobs, Schools
Washington State Board of Tax Appeals
Washington Society of CPAs
Washington IRS Office Locations
Statistics of Income (SOI) Bulletin – Winter 2014 (entire publication in PDF)
Individual Income Tax Returns, Preliminary Data, 2012
by Michael Parisi
For Tax Year 2012, taxpayers filed 144.9 million U.S. individual income tax returns, a decrease of 0.4 percent from the 145.6 million returns filed for Tax Year 2011. This decrease occurred because of the large decline in returns filed by taxpayers in the smaller adjusted gross income (AGI) classifications. The largest decrease (3.9 percent) was a 1.5 million change in the number of returns with an AGI of under $15,000.
Excel Tables: 1
Related Link: Individual Income Tax Returns
Sales of Capital Assets Panel Data Reported on Individual Tax Returns, 2004–2007
by Janette Wilson and Pearson Liddell
The IRS Statistics of Income (SOI) Division collects data on the sales of capital assets to identify trends in the capital gains and losses reported on individual tax returns. In 1999, SOI began a panel study of individual taxpayers to measure the trends in taxes and income, including capital gains and losses, at different points in time. SOI designed the panel sample to represent all Tax Year 1999 returns, including late returns.
Excel Tables: 1, 2, 3, 4, 5
Split-Interest Trusts, Filing Year 2012
by Lisa Schreiber Rosenmerkel
The number of Forms 5227 filed with the IRS has consistently declined in recent years. Preparers filed 113,688 Forms 5227 with the IRS in Filing Year 2012, a 3.4-percent decline from Filing Year 2011.
Excel Tables: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Related Link: Split-Interest Trust Statistics
Nonprofit Charitable Organizations, 2010
by Paul Arnsberger
Nonprofit charitable organizations exempt from income tax under Internal Revenue Code (IRC) section 501(c)(3) filed 269,474 Forms 990 and 990-EZ and reported $2.9 trillion in assets for Tax Year 2010, an increase of 9 percent from the previous year.
Excel Tables: 1, 2, 3, 4
Related Link: Charities and Other Tax-Exempt Organizations Statistics
- SOI Sampling Methodology and Data Limitations
- SOI Projects, Contacts, and Public Release Information
- SOI Products and Services
In the Next Issue
The following articles are tentatively planned for inclusion in the spring 2014 issue of the Statistics of Income Bulletin, scheduled to be published in May 2014:
- Individual income tax rates and tax shares, 2011;
- High-income tax returns, 2011;
- Individual foreign-earned income and foreign tax credit, 2011;
- Exempt organizations unrelated business income taxes, 2010;
- Municipal bonds, 2011; and
- Large nonoperating foundations panel, Tax Year 1998–2010
Historical Tables and Appendix
Return to Tax Stats home page
Page Last Reviewed or Updated: 19-Jun-2014
WHEREAS,the University of Washington, as required by statute, recently released its summaryof existing knowledge regarding the causes, impacts, and effects of
climate change on Washington State con including
Human activities have increased atmospheric levels of greenhouse gases to levels unprecedented in at least the past 800,000 years;
Washington has experienced long-term warming, a lengthening of the frost-free season,and more frequent nighttime heat waves. Sea level is rising along most of Washington’s coast, coastal ocean acidity has increased, glacial area and spring snowpack have declined, and peak streamflows in many rivers have shifted earlierin the year
Three key areas of risk, specifically changes in the natural timing of water availability, sea level rise and ocean acidity, and increased forest mortality, will likely bring significant consequences for the economy, infrastructure, natural systems, and human health of the region;and Decisions made today about greenhouse gas emissions will have a significant effect onthe amount of warming that will occur after mid-century;WHEREAS, studies conducted by the University of Oregon found that the effects of climate
change on water supplies, public health, coastal and storm damage, wildfires,and other impacts,will cost Washington almost $10 billion per year after 2020, unless we take additional actions to
mitigate these effects
Link to Washington State Jovernor Jay Inslee Executive orders:
Stoner Slut Shaming – Women, Weed and the Great Divide
Originally posted on The Stoner Girls' Guide:
By: Tracy Curley
Why are we trying to control the image and perception of the female cannabis user?
Recently I had a male activist, someone I felt was a friend, hit on me in a gross and insulting way. Later that weekend
when I called him on some bad business, his response was to get angry, and call me a bitch in a room full of people.
So it got me to thinking of the role of women in the cannabis business and how we are perceived not just by men but by each other.
I’ve been reading other articles about the role of women in weed, and frankly I’m as disheartened by what we are saying about each other as I am by the words and actions of the “boys club”.
Articles asking that we stop hyper-sexualizing women and weed, piss me off, because frankly that’s a much bigger…
View original 549 more words
As the Pentagon reports spending of over $1 billion on bombing ISIS in Iraq and Syria, ex-Defense Secretary Leon Panetta says the fight against the Islamist movement may take as long as 30 years.
Since mid-June, when militants from the Islamic State (also known as ISIS, or ISIL) launched their lightning offensive in Iraq, the Pentagon has spent $1.1 billion on fighting the militia, US Central Command reported Monday.
The US Navy has spent $62 million on about 185 warheads, including 47 Tomahawk cruise missiles.
The US Air Force has spent far more on munitions, dropping some 1,000 smart bombs and rockets during its sorties, AP reported CentCom as saying.
Officials say the campaign has cost an average of $7 million to $10 million a day since June. The cost escalated after the US started bombing IS positions in Iraq in early August and then expanded to Syria in September.
The report confirmed an estimate by the Center for Strategic and Budgetary Assessments (CSBA), a Washington-based think tank with ties to the Pentagon, which said a week ago that the campaign against ISIS had probably already cost between $780 and $930 million.
READ: Nearly $1bn already spent on US military campaign against ISIS
The US military spending, supported by a coalition of some 40 nations, doesn’t appear to have stopped IS from scoring new victories. Its fighters have been advancing in the battle for the Syrian Kurdish town of Kobani overnight, with two IS flags still visible over the eastern side of the town, Reuters reported.
The fight against IS may take quite a long time, according former Pentagon chief Leon Panetta, who said “we’re looking at kind of a 30-year war” in an interview with USA Today.
“It’s going to take a long time to go after these elements,” he said.
Panetta, whose memoir, “Worthy Fights,” is about to hit bookstores, criticizes President Barack Obama in the book for rushing the Iraq withdrawal in 2011. The decision was based on the assumption that Iraq’s own US-trained army and security forces would be able to provide security in the country. But in reality, Iraq slid into a violent quagmire that culminated with a surprise insurgent offensive that Baghdad’s troops did little to prevent.
***Note from Anna: How many hospitals, schools, elder care centers, or food programs could this money be funding? How many jobs could be created? Endless war budgets have gutted the taxpayers, made the world’s weapons companies CEOs (and the politicians who support them) billionaires while leaving America completely unsafe militarily, socially, and health-wise.
How many epidemics(aside from Ebola) will spread across America as funding from healthcare is diverted to endless wars overseas? Everyone loses. VOTE THEM *ALL* OUT IN 2016.
Remove *all* of the rotten-to-the-core, unrepentant judges, cops, lobbyists, and politicians from the past two generations of Republicans, Democrats, Moderates,and extremists need to be shown the door. They are finished.
Jill Stein for President 2016
Green Party Presidential Candidate Jill Stein: Downsize the Military
Presidential Candidate JILL STEIN on War on Drugs, Women’s Rights, and more.
Green Party’s Jill Stein On The Drug War | NewsBreaker | Ora TV
State of Colorado
LEGISLATIVE AUDIT COMMITTEE
Representative Angela Williams
Senator Steve King
Senator Lucia Guzman
Representative Su Ryden
Senator Owen Hill
Representative Jerry Sonnenberg
Representative Dan Nordberg Senator Lois Tochtrop
OFFICE OF THE STATE AUDITOR
Dianne E. Ray
Deputy State Auditor
Legislative Audit Manager
Dianne E. Ray, CPA
Office of the State Auditor
June 25, 2013
Members of the Legislative Audit Committee:
This report contains the results of a performance audit of Colorado’s medical marijuana
regulatory system. The audit was conducted pursuant to Section 2-3-103, C.R.S., which
authorizes the State Auditor to conduct audits of all departments, institutions, and agencies of
state government. This second of two reports presents our findings, conclusions, and
recommendations and the responses of the Department of Public Health and Environment and
the Department of Revenue. The first report was released in March 2013.